Active, not recruitingEarly Phase 1NCT04083950
Induction of Gut Permeability by an Oral Vaccine
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- USDA, Western Human Nutrition Research Center
- Principal Investigator
- Danielle Lemay, PhD, LMFT, LPCCUSDA, ARS, Western Human Nutrition Research Center
- Intervention
- Vivotif Typhoid Oral Vaccine(biological)
- Enrollment
- 10 target
- Eligibility
- 18-49 years · FEMALE
- Timeline
- 2019 – 2026
Study locations (1)
- USDA, ARS, Western Human Nutrition Research Center, Davis, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04083950 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore